Protalix BioTherapeutics, Inc. Notes Payable, Current
Protalix BioTherapeutics, Inc. (PLX) had Notes Payable, Current of $4.09 million as of 2020-12-31, per its 10-K filed 2022-03-31.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:NotesPayableCurrent · last filed 2022-03-31
- 2020-12-31: Notes Payable, Current $4.09M.
- 2020-09-30: Notes Payable, Current $4.30M.
- 2020-06-30: Notes Payable, Current $4.30M.
- 2020-03-31: Notes Payable, Current $4.30M.
| Period end | Notes Payable, Current |
|---|---|
| 2020-12-31 | $4.09M 10-K · filed 2022-03-31 |
| 2020-09-30 | $4.30M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $4.30M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $4.30M 10-Q · filed 2020-06-01 |
| 2019-12-31 | $4.30M 10-K · filed 2021-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |